BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 20081177)

  • 21. Long-term administration of a commercial porcine reproductive and respiratory syndrome virus (PRRSV)-inactivated vaccine in PRRSV-endemically infected sows.
    Papatsiros VG; Alexopoulos C; Kritas SK; Koptopoulos G; Nauwynck HJ; Pensaert MB; Kyriakis SC
    J Vet Med B Infect Dis Vet Public Health; 2006 Aug; 53(6):266-72. PubMed ID: 16907957
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of vaccination of pigs against experimental infection with high and low virulence Mycoplasma hyopneumoniae strains.
    Villarreal I; Maes D; Vranckx K; Calus D; Pasmans F; Haesebrouck F
    Vaccine; 2011 Feb; 29(9):1731-5. PubMed ID: 21237277
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical evaluation of intradermal vaccination against porcine enzootic pneumonia (Mycoplasma hyopneumoniae).
    Tassis PD; Papatsiros VG; Nell T; Maes D; Alexopoulos C; Kyriakis SC; Tzika ED
    Vet Rec; 2012 Mar; 170(10):261. PubMed ID: 22262700
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vaccination of piglets at 1 week of age with an inactivated Mycoplasma hyopneumoniae vaccine reduces lung lesions and improves average daily gain in body weight.
    Wilson S; Van Brussel L; Saunders G; Taylor L; Zimmermann L; Heinritzi K; Ritzmann M; Banholzer E; Eddicks M
    Vaccine; 2012 Dec; 30(52):7625-9. PubMed ID: 23084853
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Natural infection with torque teno sus virus 1 (TTSuV1) suppresses the immune response to porcine reproductive and respiratory syndrome virus (PRRSV) vaccination.
    Zhang Z; Wang Y; Fan H; Lu C
    Arch Virol; 2012 May; 157(5):927-33. PubMed ID: 22327391
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A candidate multi-epitope vaccine against porcine reproductive and respiratory syndrome virus and Mycoplasma hyopneumoniae induces robust humoral and cellular response in mice.
    Gao Z; Chen L; Song T; Pan X; Li X; Lu G; Tang Y; Wu X; Zhao B; Zhang R
    Vaccine; 2022 Apr; 40(16):2370-2378. PubMed ID: 35307227
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reproductive performance of gilts following vaccination and subsequent heterologous challenge with European strains of porcine reproductive and respiratory syndrome virus.
    Scortti M; Prieto C; Simarro I; Castro JM
    Theriogenology; 2006 Nov; 66(8):1884-93. PubMed ID: 16806451
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Field trial on the simultaneous vaccination against porcine circovirus type 2 (PCV2) and Mycoplasma hyopneumoniae].
    Herbich E; Heissenberger B; Ladinig A; Griessler A; Ritzmann M; Weissenbacher-Lang C; Hennig-Pauka I
    Tierarztl Prax Ausg G Grosstiere Nutztiere; 2013; 41(5):279-88. PubMed ID: 24126996
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of vaccination with a modified-live porcine reproductive and respiratory syndrome virus vaccine on dynamics of homologous viral infection in pigs.
    Cano JP; Dee SA; Murtaugh MP; Trincado CA; Pijoan CB
    Am J Vet Res; 2007 May; 68(5):565-71. PubMed ID: 17472459
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protection and immune response in pigs intradermally vaccinated against porcine reproductive and respiratory syndrome (PRRS) and subsequently exposed to a heterologous European (Italian cluster) field strain.
    Martelli P; Cordioli P; Alborali LG; Gozio S; De Angelis E; Ferrari L; Lombardi G; Borghetti P
    Vaccine; 2007 Apr; 25(17):3400-8. PubMed ID: 17276558
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Occurrence and severity of lung lesions in slaughter pigs vaccinated against Mycoplasma hyopneumoniae with different strategies.
    Hillen S; von Berg S; Köhler K; Reinacher M; Willems H; Reiner G
    Prev Vet Med; 2014 Mar; 113(4):580-8. PubMed ID: 24485705
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of porcine circovirus type 2 (PCV2) vaccination on porcine reproductive and respiratory syndrome virus (PRRSV) and PCV2 coinfection.
    Opriessnig T; Madson DM; Prickett JR; Kuhar D; Lunney JK; Elsener J; Halbur PG
    Vet Microbiol; 2008 Sep; 131(1-2):103-14. PubMed ID: 18430525
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Similarity of European porcine reproductive and respiratory syndrome virus strains to vaccine strain is not necessarily predictive of the degree of protective immunity conferred.
    Prieto C; Alvarez E; Martínez-Lobo FJ; Simarro I; Castro JM
    Vet J; 2008 Mar; 175(3):356-63. PubMed ID: 17560818
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of modified-live porcine reproductive and respiratory syndrome virus (PRRSv) vaccine on the shedding of wild-type virus from an infected population of growing pigs.
    Linhares DC; Cano JP; Wetzell T; Nerem J; Torremorell M; Dee SA
    Vaccine; 2012 Jan; 30(2):407-13. PubMed ID: 22063389
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of a modified-live virus vaccine against porcine reproductive and respiratory syndrome in boars.
    Christopher-Hennings J; Nelson EA; Nelson JK; Benfield DA
    Am J Vet Res; 1997 Jan; 58(1):40-5. PubMed ID: 8989494
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of porcine reproductive and respiratory syndrome virus vaccine and porcine interleukin-12.
    Wee GJ; Cao MJ; Liu W; Kwang J
    Vet Ther; 2001; 2(2):112-9. PubMed ID: 19753703
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of the efficacy of commercial porcine reproductive and respiratory syndrome virus (PRRSV) vaccines based on measurement of serologic response, frequency of gamma-IFN-producing cells and virological parameters of protection upon challenge.
    Zuckermann FA; Garcia EA; Luque ID; Christopher-Hennings J; Doster A; Brito M; Osorio F
    Vet Microbiol; 2007 Jul; 123(1-3):69-85. PubMed ID: 17376612
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunologic responses and reproductive outcomes following exposure to wild-type or attenuated porcine reproductive and respiratory syndrome virus in swine under field conditions.
    Lowe JF; Zuckermann FA; Firkins LD; Schnitzlein WM; Goldberg TL
    J Am Vet Med Assoc; 2006 Apr; 228(7):1082-8. PubMed ID: 16579789
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of genetic diversity of European-type porcine reproductive and respiratory syndrome virus strains on vaccine efficacy.
    Labarque G; Reeth KV; Nauwynck H; Drexler C; Van Gucht S; Pensaert M
    Vaccine; 2004 Oct; 22(31-32):4183-90. PubMed ID: 15474708
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of live attenuated porcine reproductive and respiratory syndrome virus 2 strains to protect pigs from challenge with a heterologous Vietnamese PRRSV 2 field strain.
    Sattler T; Pikalo J; Wodak E; Revilla-Fernández S; Steinrigl A; Bagó Z; Entenfellner F; Claude JB; Pez F; Francillette M; Schmoll F
    BMC Vet Res; 2018 Apr; 14(1):133. PubMed ID: 29673363
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.